Michel Cucherat
Overview
Explore the profile of Michel Cucherat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1995
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barret L, Liaigre L, Hlavaty A, Giai J, Laporte S, Ollier E, et al.
J Clin Epidemiol
. 2024 Dec;
179():111651.
PMID: 39724990
Objectives: To describe the priors and decision thresholds in phase 2 and 3 randomized controlled trials (RCTs) evaluating drug efficacy using Bayesian methods. Study Design And Setting: A systematic review...
2.
Cucherat M, Demarcq O, Chassany O, Le Jeunne C, Borget I, Collignon C, et al.
Therapie
. 2024 Dec;
80(1):47-59.
PMID: 39694790
The issue of assessing the effectiveness of health technologies (drugs, devices, etc.) through observational studies is becoming increasingly important as registration and market access agencies consider them in their evaluation...
3.
Cucherat M, Demarcq O, Chassany O, Le Jeunne C, Borget I, Collignon C, et al.
Therapie
. 2024 Nov;
80(1):33-46.
PMID: 39537531
No abstract available.
4.
Peron A, Picot C, Jurek L, Nourredine M, Ripoche E, Ajiji P, et al.
BMC Pregnancy Childbirth
. 2024 Feb;
24(1):103.
PMID: 38308208
Background: Lamotrigine has become one of the most commonly prescribed antiseizure medications (ASM) in epileptic women during pregnancy and therefore requires regular updates regarding its safety. The aim of this...
5.
Locher C, Laporte S, Derambure P, Chassany O, Girault C, Avakiantz A, et al.
Therapie
. 2023 Dec;
79(1):111-121.
PMID: 38103949
Clinical trials often last several months or even several years. As the trial progresses, it can be tempting to find out whether the data obtained already answers the question posed...
6.
Lafarge J, Aron-Wisnewsky J, Pattou F, Cucherat M, Blondet E, Lascols S, et al.
Diabetes Metab
. 2023 Nov;
50(1):101495.
PMID: 38000504
Objective: Randomized controlled trials (RCTs) have demonstrated the superiority of metabolic surgery (MS) over medical therapy (MT) in patients with obesity and type 2 diabetes, leading, to a joint statement...
7.
Locher C, Laporte S, Derambure P, Chassany O, Girault C, Avakiantz A, et al.
Therapie
. 2023 Nov;
79(1):99-110.
PMID: 37985309
No abstract available.
8.
Chapelle C, Ollier E, Bonjean P, Locher C, Zufferey P, Cucherat M, et al.
J Clin Epidemiol
. 2023 Aug;
162:98-106.
PMID: 37648071
Objectives: To perform an overview of the overlap of systematic reviews (SRs) assessing direct oral anticoagulants and characterize these reviews in terms of bias and methodological quality (PROSPERO: CRD42022316273). Study...
9.
Picot C, Ajiji P, Jurek L, Nourredine M, Massardier J, Peron A, et al.
Syst Rev
. 2023 Jun;
12(1):101.
PMID: 37344917
Background: Knowledge about the risks of drugs during pregnancy is continuously evolving due to the frequent publication of a large number of epidemiological studies. Systematic reviews and meta-analyses therefore need...
10.
Peron A, Ripoche E, Picot C, Ajiji P, Cucherat M, Cottin J
Reprod Toxicol
. 2023 Jun;
119:108419.
PMID: 37269915
Use of proton pump inhibitors (PPI) are common among pregnant women to relieve gastrointestinal symptoms. The number of exposed pregnancies is therefore considerable, and a recent meta-analysis (MA) from 2020...